rfhg_186919.1

Basic information about the TSS

---

TSS ID: rfhg_186919.1 TSS ID(Version3): hg_158334.1 hg_158337.1 hg_158335.1 hg_158336.1 Species: human Chr: chr16		Start: 84116788 End: 84116953 Strand: -
Source datasets	FANTOM5|PRJDB5282|PRJNA4843412|DRA013844|PRJNA401781 |PRJNA548673|PRJNA615891|PRJNA597322
Protocol	CAGE|C1CAGE|NETCAGE|oligo_capping|ReCappable-seq|TIF-seq2 |SLIC_CAGE|RAMPAGE|STRIPE-seq
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2891312,EH38E1832967)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000343411.8:0 ENST00000570012.1:0 ENST00000569907.5:0 ENST00000567557.1:0 ENST00000564444.1:0 D42053:0 BC026330:0 AK299067:0 AK291773:0 BC114555:0 BC114961:0 GeneID: 8720 HGNC/MGI_ID: HGNC:15456 UniProt_ID: B4DR21 H3BS61 H3BV53 Q14703 Nearer transcript ids and distances:

Gene_name: membrane bound transcription factor peptidase, site 1 Gene_symbol: MBTPS1 Gene_synonyms: KIAA0091 PCSK8 S1P SKI-1 Gene_source: HGNC:15456

TATA-Box annotation

---

Distance to TSS:	72
Nearest PromoterID:	NM_003791
Entrez ID:	8720
Nearest Unigene:	Hs.75890
Nearest Refseq:	NM_003791
Nearest Ensembl:	ENSG00000140943
Gene Name:	membrane bound transcription factor peptidase, site 1
Gene Alias:	PCSK8|S1P|SEDKF|SKI-1
Gene Type:	protein-coding
CpG%:	0.115152
GC%:	0.716867
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MBTPS1 p2@MBTPS1 p3@MBTPS1 p4@MBTPS1 p5@MBTPS1
Sample		p1@MBTPS1	p2@MBTPS1	p3@MBTPS1	p4@MBTPS1	p5@MBTPS1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	6.23	13.05	1.95	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.28	12.14	1.01	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.29	12.73	0.77	0.77	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.20	9.15	0.83	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.52	9.45	0.90	0.22	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.56	10.47	2.13	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	9.59	16.56	2.18	1.09	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.30	13.81	0.97	0.48	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	9.40	15.17	0.85	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.06	15.07	1.16	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.06	10.11	2.83	0.81	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.29	12.60	2.44	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.08	11.77	0.16	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.60	7.52	0.45	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.69	9.66	0.22	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.57	7.29	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.07	9.61	0.22	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.29	3.80	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.66	9.06	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.95	7.52	0.75	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.44	9.49	0.40	0.67	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.89	8.98	0.17	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.80	7.11	0.39	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.56	9.46	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.42	9.29	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	17.72	8.23	0.32	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.23	7.14	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	20.75	11.32	0.00	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.31	11.15	0.48	0.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.28	10.13	0.36	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.12	9.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.70	8.21	0.78	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	19.63	8.65	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	28.70	9.07	0.49	0.33	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.88	10.28	0.75	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.82	9.77	0.38	0.57	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.26	7.97	0.61	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.30	8.87	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	16.48	9.99	0.27	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.20	7.92	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.94	8.47	1.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	22.25	8.34	0.29	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.56	9.28	0.42	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	17.31	7.34	0.70	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	21.88	9.24	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.01	10.00	0.70	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.95	9.84	0.00	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.37	7.15	0.00	0.30	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.06	10.29	0.96	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.44	7.08	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.58	7.79	1.02	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.24	8.67	0.89	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.39	7.81	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.25	7.29	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	15.94	0.84	3.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	27.10	9.18	0.92	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.99	10.37	0.65	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.56	6.42	0.32	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	26.09	9.12	1.26	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	7.05	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.14	10.09	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	44.58	9.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.54	8.83	1.02	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	8.77	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.52	6.03	1.06	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	252.72	23.69	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	16.58	2.44	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.85	4.96	0.00	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	17.83	9.38	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.51	4.64	0.00	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.40	6.19	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.45	5.81	0.61	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	26.77	22.49	0.95	0.95	0.48
Adipocyte - breast, donor2	11327-117E4	18.93	16.04	2.09	0.32	1.44
Adipocyte - omental, donor1	11473-119C6	30.66	22.77	0.76	1.65	0.51
Adipocyte - omental, donor2	11474-119C7	18.69	20.93	0.75	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	15.74	14.74	1.67	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	19.14	23.61	1.28	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.52	14.90	1.35	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	13.90	16.51	0.70	1.04	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	25.82	33.44	0.59	1.56	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	22.65	15.96	1.54	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	35.40	13.10	1.12	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	29.39	19.99	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	22.84	26.54	0.48	0.56	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	27.11	14.85	0.97	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	21.33	9.60	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	18.92	16.14	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.05	18.72	0.00	2.08	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	20.09	15.32	1.26	0.25	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	13.09	13.09	0.98	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	15.22	14.31	0.61	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	14.81	21.88	1.10	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	6.10	1.08	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	35.98	25.37	1.26	2.16	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	18.41	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	31.02	28.35	0.00	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	28.03	23.91	0.69	0.69	1.03
Anulus Pulposus Cell, donor2	11463-119B5	24.98	24.98	0.73	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.57	16.17	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.67	14.33	1.30	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	14.98	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.84	17.04	2.09	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	21.50	20.23	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	12.54	1.32	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.22	10.40	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	19.90	12.14	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	22.57	15.44	0.59	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.83	12.81	0.75	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	14.51	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	6.27	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.27	15.65	1.32	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	16.38	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	18.09	13.42	1.51	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	22.50	15.00	0.54	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.41	16.44	1.13	0.19	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	23.79	10.96	1.07	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	15.61	14.63	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.57	15.42	0.83	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	9.61	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.01	14.41	0.86	0.51	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	23.79	14.08	1.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	21.63	18.59	1.52	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	12.11	0.00	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.38	12.54	0.57	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.53	14.96	1.28	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.36	10.84	1.03	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	16.89	10.79	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.33	13.83	0.96	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	12.84	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.96	11.11	1.75	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.87	12.04	0.60	0.60	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	10.69	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	18.31	13.22	1.53	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.34	14.52	0.76	0.00	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.88	9.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	23.73	12.51	0.43	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	18.63	12.49	1.06	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.66	8.99	0.29	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	21.73	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.63	14.24	0.85	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	25.48	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	12.68	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.23	13.29	1.07	0.86	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.05	7.22	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	19.68	16.77	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	19.31	17.47	1.84	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	25.50	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.37	17.29	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	23.74	14.45	1.65	0.62	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.85	15.91	0.92	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	17.21	1.91	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.85	15.74	1.11	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	7.63	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	11.63	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.80	14.30	0.53	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.81	11.27	1.45	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	24.56	21.25	1.11	0.12	0.74
Astrocyte - cerebellum, donor2	11580-120F5	21.57	22.25	1.03	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	24.33	11.33	0.84	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	23.70	19.87	1.05	1.74	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	24.27	16.82	0.81	0.97	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	19.24	16.26	0.45	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	11.81	17.43	0.00	0.34	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	10.90	14.03	0.13	0.38	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11.38	20.37	0.00	0.68	0.11
Basophils, donor1	12241-129G9	32.95	20.66	0.26	1.05	0.00
Basophils, donor2	12242-129H1	65.66	31.03	1.80	0.72	2.53
Basophils, donor3	12243-129H2	27.19	15.73	1.18	0.59	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	11.00	11.00	0.22	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	2.74	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.93	11.30	0.63	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.02	19.55	0.42	0.83	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	9.44	18.19	0.23	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	10.98	11.52	0.36	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.92	20.40	0.41	0.62	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	30.28	19.10	0.47	0.00	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	28.46	10.55	0.32	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	31.03	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	34.94	19.72	1.13	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	30.62	18.56	1.86	0.56	0.37
CD14+ Monocytes, donor3	11381-118B4	32.93	18.44	2.41	1.10	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	28.30	6.51	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	29.19	8.72	0.00	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.30	7.23	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	27.46	5.20	3.18	0.87	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	20.22	4.53	2.11	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	27.95	9.24	1.18	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	18.58	5.36	1.17	0.17	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	11.87	3.04	1.66	0.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	13.64	5.95	0.74	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.22	3.13	1.17	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.68	3.20	1.42	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	17.85	6.53	1.31	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.79	7.96	0.94	0.70	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.37	12.67	1.58	0.00	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	17.75	9.98	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	17.85	5.06	1.34	0.00	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.37	4.59	2.00	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.44	6.04	0.83	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.41	5.26	1.14	0.00	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	11.31	5.20	1.36	0.23	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	14.84	6.11	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	20.98	5.38	1.34	1.08	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	21.63	6.46	1.74	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	20.20	8.00	0.42	1.26	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.96	4.41	0.73	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.57	6.69	1.06	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.04	6.58	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	14.65	2.96	0.52	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	14.12	5.20	0.37	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	18.75	6.68	1.08	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.33	6.14	1.64	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.91	6.26	0.46	0.23	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.30	6.50	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	26.59	9.15	0.65	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	24.95	7.85	0.23	0.23	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	27.08	6.50	1.30	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	47.34	16.20	1.25	1.25	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	30.04	8.91	1.22	0.35	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	51.95	19.18	2.45	1.11	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	22.46	7.40	0.51	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	23.05	7.03	0.22	0.22	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	31.37	7.16	0.42	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	28.45	32.52	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	35.93	25.76	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	52.82	19.68	3.11	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	46.91	21.32	0.00	0.00	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	39.13	28.41	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	43.52	33.69	0.00	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	32.16	25.88	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	32.96	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	43.56	36.99	2.47	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	37.72	36.27	1.45	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	38.37	35.34	0.00	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	11.72	23.44	0.81	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.59	12.38	0.80	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	31.13	11.04	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	37.08	23.60	0.00	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.16	16.16	1.13	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	28.64	18.26	0.00	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	80.34	46.42	1.43	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	61.24	37.97	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	54.29	32.63	2.13	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	33.44	17.61	0.26	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	33.91	23.13	0.45	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	40.53	18.11	0.29	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	78.23	53.57	1.42	1.42	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	90.60	51.97	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	79.11	42.85	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	24.42	17.63	1.16	0.72	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	17.45	15.42	0.00	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.02	16.60	0.16	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	53.35	21.52	1.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	53.11	20.61	1.40	0.35	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	65.12	29.04	0.44	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	27.83	14.76	0.00	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.98	11.43	0.21	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.38	9.69	0.33	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	76.69	55.20	1.09	0.27	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	84.14	69.67	2.14	1.07	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	73.52	37.66	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	28.37	16.50	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	22.31	13.65	0.22	0.22	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.85	12.40	0.42	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	60.67	31.35	2.02	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	59.36	28.16	0.43	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	74.09	32.69	0.44	1.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	69.28	43.55	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	62.78	46.16	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	54.44	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	63.97	39.32	0.55	1.11	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	68.71	44.91	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	69.30	38.50	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	69.12	37.96	0.00	1.43	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	55.40	44.32	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	58.60	45.84	0.98	1.31	0.98
CD8+ T Cells, donor2	11307-117C2	44.30	31.16	1.13	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	67.67	42.42	1.26	1.01	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.13	8.26	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.95	6.23	1.20	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.29	6.29	0.82	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.20	7.81	0.90	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.88	6.96	0.24	0.00	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.00	7.50	0.68	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.91	6.74	1.09	0.65	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.68	3.95	0.79	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.46	7.27	0.70	0.23	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.43	7.25	1.21	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.78	4.07	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.99	8.26	1.07	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.06	4.82	0.88	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2.73	5.47	1.82	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.24	4.48	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.96	9.00	0.72	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.62	7.19	0.58	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.95	5.89	0.94	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.02	7.92	0.63	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.69	6.15	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.09	8.01	0.96	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.06	6.50	0.76	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	6.31	6.31	0.39	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.03	6.05	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.01	12.04	0.00	0.00	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.29	9.79	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	13.02	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	14.62	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.25	12.35	2.47	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	26.52	21.68	0.84	1.58	0.00
Chondrocyte - de diff, donor1	11261-116G1	22.53	22.19	1.04	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	25.23	28.79	1.42	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	24.58	18.20	0.11	0.80	0.34
Chondrocyte - re diff, donor2	11339-117F7	42.97	43.87	3.58	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	27.90	19.41	1.21	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	34.66	25.13	0.46	1.15	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	24.37	26.29	0.43	1.28	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	26.20	22.57	1.06	0.62	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	41.91	23.84	1.19	1.01	0.64
Corneal Epithelial Cells, donor1	11526-119I5	9.44	11.64	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	13.65	0.00	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	12.27	15.59	0.26	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.70	11.56	0.83	0.83	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	15.14	10.41	0.32	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	20.70	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.63	10.80	0.11	0.54	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	26.99	20.50	1.02	0.68	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	40.48	16.97	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	34.84	28.07	1.94	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	32.19	20.35	0.50	1.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	11.74	0.59	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	33.09	18.66	2.55	2.55	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	30.28	17.69	2.36	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	19.20	7.85	2.04	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	22.59	14.35	0.47	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	28.05	14.73	1.58	0.70	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	30.37	20.61	0.44	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	34.08	22.21	1.22	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	40.88	21.14	0.85	0.28	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	26.44	16.64	0.59	1.49	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	28.12	1.56	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.43	10.78	0.43	0.28	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	28.01	22.41	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	22.01	10.48	0.52	2.62	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	41.00	28.33	1.62	0.87	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	25.85	19.34	0.43	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.62	18.81	0.98	0.24	0.49
Endothelial Cells - Vein, donor1	11267-116G7	14.79	10.24	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.76	18.86	1.40	1.40	0.70
Endothelial Cells - Vein, donor3	11416-118F3	25.44	14.60	0.94	1.10	0.63
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	26.40	23.10	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	3.57	14.27	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.77	12.22	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	6.24	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.04	20.94	1.64	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.21	12.15	0.22	0.22	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.18	14.19	0.87	0.22	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.62	19.28	0.73	1.09	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.15	23.88	1.50	1.09	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.03	18.98	0.74	0.53	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	38.21	31.09	0.79	1.32	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.26	15.28	1.00	1.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	17.69	16.33	0.91	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	12.13	8.34	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.67	9.94	1.10	0.63	0.79
Fibroblast - Cardiac, donor4	11452-119A3	29.70	26.37	2.12	1.21	0.91
Fibroblast - Cardiac, donor5	11456-119A7	32.49	15.48	1.27	1.02	0.76
Fibroblast - Cardiac, donor6	11460-119B2	23.50	18.04	2.12	0.45	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.84	29.75	0.80	1.21	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.28	9.92	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	20.51	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	31.14	20.76	0.23	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	40.54	19.33	1.36	1.19	0.00
Fibroblast - Dermal, donor1	11269-116G9	10.10	15.73	0.94	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	10.38	21.23	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.51	14.14	0.48	0.48	0.12
Fibroblast - Dermal, donor4	11450-119A1	16.96	15.71	0.90	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	16.92	18.32	0.17	0.70	0.00
Fibroblast - Dermal, donor6	11458-119A9	19.33	20.95	0.81	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	21.86	19.78	0.42	0.42	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	31.70	17.29	1.57	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	17.92	14.23	0.40	1.32	0.13
Fibroblast - Gingival, donor3	11394-118C8	23.20	15.66	0.39	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	18.70	2.08	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.43	14.62	0.70	0.70	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.29	21.05	1.09	0.47	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	22.04	11.49	1.08	0.41	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.70	10.23	0.35	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.08	14.77	0.58	0.44	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	26.04	13.50	0.68	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.58	10.75	1.43	0.88	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	41.38	18.78	1.03	0.88	0.29
Fibroblast - Lung, donor1	11270-116H1	14.95	13.59	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	29.84	28.35	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.67	11.40	0.21	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	29.16	29.16	1.67	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	11.19	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.56	6.72	1.40	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	27.61	36.13	1.22	1.62	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	15.98	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	29.78	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	22.69	14.16	0.39	0.97	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	21.99	21.08	0.15	0.46	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.67	17.14	0.92	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	23.66	16.41	0.38	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	20.25	12.69	0.27	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.83	17.74	0.70	0.93	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.75	16.91	1.55	1.66	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	27.63	26.01	0.61	1.22	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	26.06	18.04	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.19	12.65	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	41.67	21.43	1.59	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	40.32	15.63	0.53	1.42	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.93	23.06	1.18	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	31.59	16.55	1.81	1.20	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	35.95	15.98	2.16	0.43	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.76	17.21	1.01	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	32.00	25.10	0.16	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	41.30	24.86	1.40	1.60	0.60
Fibroblast - skin normal, donor2	11561-120D4	34.36	23.01	1.21	1.41	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.31	31.73	0.30	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	54.18	18.06	0.33	1.16	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	44.28	20.86	1.20	0.34	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	34.16	16.75	1.64	3.28	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	36.43	22.05	2.02	1.17	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	28.17	15.18	1.18	0.67	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	34.66	19.45	0.78	0.63	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	9.59	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.20	14.56	0.87	0.17	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.12	21.34	1.04	1.82	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.31	20.19	0.77	0.26	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.20	8.42	2.30	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	16.59	8.29	0.64	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	32.81	17.40	2.00	0.29	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	29.78	23.99	0.00	0.28	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	18.95	18.27	0.46	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	21.20	16.25	0.40	0.40	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	22.73	14.54	0.00	0.26	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	17.94	21.85	0.65	0.98	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	31.84	13.27	1.33	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	10.74	11.02	1.13	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.58	10.84	1.11	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.40	9.13	1.07	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.12	4.96	0.37	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	15.09	5.68	0.42	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.15	7.12	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.50	6.39	1.60	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.20	6.35	0.37	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	12.46	5.90	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	16.55	8.27	0.00	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	20.66	10.65	1.27	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	11.17	7.60	0.45	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	23.19	6.05	0.60	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.58	8.99	1.70	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.35	12.06	0.80	0.53	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.35	8.84	0.21	0.31	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.64	7.34	0.34	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.23	11.07	2.10	0.11	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.13	10.32	0.83	0.08	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.38	12.46	0.41	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.28	6.19	1.03	0.00	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.02	10.03	0.46	0.46	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.01	6.67	1.50	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	20.06	7.72	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.30	8.49	0.74	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	19.78	10.21	1.78	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.92	10.58	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	22.36	10.80	1.23	0.38	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.08	6.49	0.32	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	19.77	8.51	0.00	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	22.68	8.47	0.84	0.00	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.20	5.71	0.22	0.22	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.88	8.14	0.84	0.00	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	19.17	9.35	1.11	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.37	10.96	1.07	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	19.58	9.18	1.38	0.61	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.10	7.64	1.81	0.13	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.62	6.78	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.07	12.54	1.66	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	22.37	11.40	1.10	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	25.79	9.92	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.72	8.31	1.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.00	7.67	0.61	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	31.26	17.79	1.52	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	15.53	9.75	1.79	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	10.48	7.70	0.31	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	17.80	8.39	1.43	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.65	11.89	0.63	1.25	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.13	7.35	0.28	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	18.91	12.91	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	17.32	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	14.31	12.76	1.93	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	14.44	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	13.91	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.30	12.37	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	17.71	13.59	2.06	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	10.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	21.25	9.79	0.56	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	16.02	10.46	0.98	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	25.17	7.55	1.68	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	23.54	9.54	0.64	0.32	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.34	11.21	2.72	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	14.62	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.34	12.60	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	14.50	6.51	1.48	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	10.16	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	20.71	12.01	2.49	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	17.95	11.74	0.92	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.53	11.92	1.15	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.86	9.78	1.30	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	4.68	2.68	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	24.27	11.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.25	12.32	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	14.91	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	22.65	13.21	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	32.59	6.64	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	28.49	11.70	1.02	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	23.93	10.37	0.80	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	23.19	13.32	0.49	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	5.90	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	21.59	11.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.46	9.66	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	23.74	11.87	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	12.54	0.60	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.13	14.07	0.97	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	9.13	7.99	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.87	12.06	0.83	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	14.62	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	21.25	17.44	0.32	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.28	13.79	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	15.20	27.62	0.93	0.93	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.35	27.85	1.01	0.51	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.84	27.07	1.82	0.68	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.21	26.23	1.42	0.44	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.39	29.66	0.43	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.56	26.91	0.22	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.20	21.17	0.62	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.46	20.07	0.51	0.86	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.57	20.50	0.96	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.74	17.35	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	14.71	8.66	0.87	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	15.86	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.87	30.69	2.12	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.90	18.89	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.76	16.26	1.40	0.17	0.00
Hepatocyte, donor1	11523-119I2	23.00	18.16	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	37.71	21.55	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	33.74	15.34	0.61	2.45	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	32.63	28.72	1.31	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	40.37	23.25	0.35	1.40	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	31.56	17.97	1.37	0.55	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	5.54	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	15.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	7.69	2.56	0.00	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	13.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	14.62	4.87	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	8.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	6.62	10.59	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	6.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	15.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	9.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	6.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.75	9.04	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	6.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	5.70	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.40	7.98	0.84	0.42	2.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	11.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	9.23	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	5.66	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	8.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	4.30	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	2.54	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	8.29	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	7.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	7.14	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.03	5.56	0.31	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	9.43	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.95	7.65	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	15.49	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	9.73	0.00	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	13.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	15.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	17.42	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	9.60	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	11.08	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	11.05	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	9.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	18.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	8.46	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	14.69	15.75	0.57	0.65	0.57
Keratinocyte - epidermal, donor2	11349-117G8	7.03	14.64	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	13.35	10.70	0.09	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	22.25	20.32	0.11	0.34	0.57
Keratocytes, donor1	11527-119I6	34.38	18.91	0.00	1.03	0.00
Keratocytes, donor2	11607-120I5	19.92	11.72	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	30.03	10.67	0.00	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	39.56	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	12.94	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	28.14	13.26	0.46	0.69	0.46
Lens Epithelial Cells, donor3	11690-122I7	23.21	20.69	0.71	0.61	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	31.66	17.67	1.07	0.71	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	16.47	5.86	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.19	16.21	0.94	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.90	8.60	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.07	12.29	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	19.30	16.06	0.43	0.86	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.42	9.85	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.86	6.57	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.41	13.93	0.99	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.82	9.89	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.83	10.28	0.58	0.00	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	15.37	11.66	0.37	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.51	9.76	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.60	7.16	0.00	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	21.43	14.56	0.69	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.32	7.39	0.62	1.23	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	16.52	5.30	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.96	15.37	0.55	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.09	10.20	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.25	9.96	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.42	12.45	1.00	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	12.12	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.31	7.81	0.27	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	19.22	14.84	1.82	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	9.33	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.24	9.00	0.42	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.80	15.64	0.75	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.13	11.69	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.61	7.34	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.52	13.36	0.32	0.74	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.60	4.85	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.23	8.93	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.33	13.01	0.74	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.99	10.00	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.12	8.65	0.00	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.85	12.92	0.55	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.94	9.97	0.64	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.91	6.70	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	21.69	14.28	0.84	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.07	8.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.27	5.33	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.78	10.27	0.62	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.03	9.31	0.72	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.41	5.55	0.65	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.01	9.89	0.94	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	23.02	20.30	0.99	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.40	6.66	0.26	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	19.69	12.53	0.90	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	67.98	56.65	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	43.73	51.40	1.53	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.95	43.79	4.45	2.23	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	52.89	43.58	3.81	2.12	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	34.46	42.20	0.70	2.11	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	30.82	39.23	0.93	6.54	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	36.07	39.68	2.06	4.64	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	42.82	46.39	1.19	5.95	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	45.24	47.27	2.26	4.98	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	35.77	37.23	3.78	3.20	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.21	45.92	1.80	1.80	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	45.66	53.52	3.25	4.20	3.66
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	43.14	53.92	4.11	3.59	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.17	44.81	2.82	2.47	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.32	37.98	2.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	38.20	47.37	1.53	3.57	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	42.42	46.42	2.67	2.40	3.20
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	40.81	50.26	4.53	3.78	2.27
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	38.04	50.31	4.29	4.91	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	43.22	60.34	5.71	1.63	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	43.94	46.44	2.92	4.79	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	37.84	42.60	3.08	3.36	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	31.94	46.37	5.15	3.09	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.35	47.90	3.48	2.90	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	27.50	47.83	0.60	3.59	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	33.75	39.83	1.66	3.32	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.54	47.37	2.83	2.12	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	39.09	43.15	4.79	2.95	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	25.33	42.60	1.15	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	41.83	53.73	4.99	4.22	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	35.10	34.53	3.40	2.26	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	37.74	33.64	2.46	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	35.25	41.12	2.71	3.62	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	34.47	45.96	7.18	5.03	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.86	49.30	2.24	1.49	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	45.33	55.74	6.69	2.60	3.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	27.14	39.20	4.31	1.72	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	39.39	2.57	3.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	41.31	45.98	3.66	3.33	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	40.42	53.69	2.41	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	40.53	49.06	4.27	2.13	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.53	43.31	3.44	3.09	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	39.18	46.16	3.76	3.22	4.29
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	47.14	2.02	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	38.89	52.23	2.59	2.59	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	38.38	75.59	3.49	5.81	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	45.48	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	36.01	46.02	4.80	3.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.80	57.42	5.81	2.91	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	56.72	59.02	3.07	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	48.83	47.85	4.93	2.96	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	39.52	48.93	0.94	2.82	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	40.73	60.34	5.53	4.02	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.05	55.43	3.60	2.70	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	41.31	61.96	3.44	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	39.19	44.09	3.56	2.67	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	38.71	48.10	1.96	4.69	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.97	40.90	3.96	2.64	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	41.51	50.85	1.56	2.59	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	50.76	55.57	6.13	4.81	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	50.88	54.23	1.68	2.80	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	40.63	51.23	1.77	2.65	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	47.06	60.17	3.86	2.31	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	33.93	52.66	1.52	4.05	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	50.95	57.67	3.36	2.88	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	37.77	48.90	5.57	3.98	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	33.42	39.50	0.61	4.86	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	29.74	36.66	1.38	2.77	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	33.44	51.30	4.56	1.14	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	42.35	49.58	4.65	3.10	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	30.84	38.09	3.02	2.42	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	36.44	46.58	3.80	2.54	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	37.85	60.77	4.80	4.26	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.01	38.50	2.87	2.87	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	44.74	58.11	3.09	3.09	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	30.42	48.10	3.54	4.95	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	35.18	52.78	3.97	3.40	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	33.70	45.76	3.33	2.50	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	35.24	38.37	4.70	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	31.32	36.33	2.09	2.92	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	39.49	50.18	3.72	2.32	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.07	34.79	3.35	2.01	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	20.85	29.94	3.21	2.14	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.18	45.66	2.42	2.02	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	40.38	4.59	1.84	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	17.78	36.45	1.78	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	28.49	40.46	2.85	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	29.91	4.60	1.53	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	23.53	28.45	1.64	0.55	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	31.18	33.41	2.67	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	30.41	41.85	1.04	2.60	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	18.57	32.49	1.99	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	31.18	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	24.61	9.80	0.91	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	9.54	13.03	1.28	1.47	0.18
Macrophage - monocyte derived, donor3	11389-118C3	11.40	10.62	0.26	0.79	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	13.28	14.34	0.53	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	29.63	32.01	0.79	2.69	0.48
Mallassez-derived cells, donor3	11930-125I4	20.01	21.40	1.25	1.67	0.42
Mammary Epithelial Cell, donor1	11273-116H4	13.15	17.64	0.20	0.70	0.20
Mammary Epithelial Cell, donor2	11350-117G9	12.45	18.24	0.29	0.87	0.87
Mammary Epithelial Cell, donor3	11422-118F9	12.97	13.47	0.75	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	30.51	24.41	0.68	0.68	1.36
Mast cell, donor1	11563-120D6	24.66	15.90	0.11	0.76	0.32
Mast cell, donor2	11565-120D8	29.72	16.64	0.59	0.30	1.49
Mast cell, donor3	11566-120D9	35.12	21.39	0.23	1.35	0.90
Mast cell, donor4	11567-120E1	30.32	15.07	0.71	0.35	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	25.51	21.62	0.44	1.11	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	22.76	23.35	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	21.57	15.60	0.23	0.57	0.11
Mast cell, expanded, donor8	11941-126A6	24.94	13.56	0.50	0.00	0.50
Melanocyte - dark, donor1	11502-119F8	27.16	23.08	0.90	1.49	0.50
Melanocyte - dark, donor2	11582-120F7	19.03	16.27	2.08	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	14.78	12.75	0.22	0.43	0.36
Melanocyte - light, donor1	11274-116H5	15.98	6.82	0.00	0.47	0.24
Melanocyte - light, donor2	11351-117H1	15.01	7.51	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	10.41	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.03	10.83	0.10	0.52	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	19.63	8.61	0.27	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	21.16	10.71	0.80	0.27	0.00
Meningeal Cells, donor1	11493-119E8	38.09	25.80	0.87	1.36	0.25
Meningeal Cells, donor2	11573-120E7	24.21	16.73	3.08	1.76	0.00
Meningeal Cells, donor3	11654-122E7	25.18	15.57	0.41	0.90	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	18.54	28.52	1.14	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	38.34	18.92	1.61	1.01	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	15.70	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	7.89	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.26	18.21	0.64	0.85	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	18.60	15.58	1.51	0.50	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.94	22.41	0.66	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	21.92	0.00	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	15.96	18.01	1.02	0.82	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.44	24.10	0.14	0.55	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.41	13.38	0.37	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	25.26	17.10	0.53	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	27.00	16.32	0.59	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.85	26.90	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.56	14.89	0.35	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	30.65	14.07	0.63	0.63	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	17.42	0.00	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	22.01	19.89	1.06	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	19.52	22.02	1.50	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	15.46	12.00	0.36	0.51	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	5.40	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.24	11.82	0.00	1.72	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.13	10.31	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.19	8.68	0.93	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.30	6.02	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	9.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.27	10.01	0.00	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.52	9.31	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.18	7.72	0.20	0.81	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.71	8.71	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	5.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	7.98	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.97	7.00	0.21	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	4.60	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.64	5.66	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	6.71	0.00	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.78	4.77	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.42	7.61	0.48	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.61	4.42	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.21	4.84	0.69	0.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.62	6.31	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.10	2.24	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.65	4.08	0.43	1.07	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.67	8.00	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.35	3.94	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	4.56	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	6.63	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.70	5.16	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.82	6.47	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	5.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.77	3.36	0.48	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.40	6.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.51	3.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.57	4.38	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	1.10	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	3.84	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.17	4.71	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	6.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.99	7.52	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	5.69	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	4.97	0.71	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.70	8.14	1.40	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	10.81	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	2.91	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.75	7.24	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.60	9.60	0.42	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	14.44	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	5.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.69	12.52	0.57	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.67	4.56	0.83	0.14	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	5.96	0.78	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.01	12.44	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	4.45	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.34	6.67	0.80	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.46	13.77	1.80	1.20	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.76	3.39	0.99	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.65	7.64	0.64	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.51	13.49	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.58	4.93	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.36	7.39	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.80	13.76	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.82	3.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.29	6.76	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.55	16.15	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	7.01	0.82	1.24	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	5.96	0.00	1.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	8.91	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	24.31	5.91	0.66	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	10.52	8.42	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	19.57	4.35	0.79	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	15.83	7.45	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.77	4.13	0.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.92	2.40	0.27	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.64	3.73	0.23	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.73	5.50	0.73	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.34	4.28	0.53	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.28	2.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	1.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	19.57	3.26	6.52	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.96	20.04	0.86	1.51	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	22.47	0.52	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	9.34	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.59	7.10	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.25	15.59	0.95	0.57	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	19.15	3.19	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	5.44	0.68	2.04	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	44.10	14.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.53	12.56	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.55	13.02	1.63	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.76	12.16	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.24	16.40	0.21	1.68	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	44.54	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	17.37	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.32	11.64	0.81	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.20	11.79	1.81	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.82	9.63	0.82	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	26.97	12.39	1.09	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.67	15.38	1.06	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	6.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	36.43	19.69	1.31	0.66	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.76	11.22	0.49	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.69	13.23	0.71	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	11.95	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.09	15.63	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.14	15.75	0.32	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	43.46	12.42	2.07	2.07	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	68.27	20.23	5.06	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.39	19.61	0.67	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.67	17.36	0.42	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.99	12.10	1.19	0.47	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	20.17	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	36.11	0.00	0.00	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.66	11.00	1.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.43	9.47	0.90	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.92	14.28	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	11.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.81	17.41	1.14	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.10	11.73	0.98	1.30	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	8.28	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	35.73	14.47	0.90	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	9.70	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	13.96	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	15.87	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.04	9.57	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	53.23	28.13	0.91	0.30	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.63	18.79	0.22	0.88	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	15.59	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	178.83	20.44	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	16.46	15.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.96	9.44	0.94	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.01	14.53	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	7.12	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	48.75	18.14	1.13	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	106.22	25.29	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	15.53	24.22	0.50	0.99	0.50
Myoblast, donor2	11322-117D8	22.06	26.85	1.53	0.38	0.38
Myoblast, donor3	11398-118D3	18.83	20.52	0.67	1.18	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.83	10.51	0.15	0.00	0.88
Natural Killer Cells, donor1	11230-116C6	53.20	33.83	1.23	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	44.63	23.52	1.21	1.21	0.00
Natural Killer Cells, donor3	11387-118C1	50.25	33.31	0.92	1.47	0.37
Neural stem cells, donor1	11275-116H6	27.95	20.32	0.73	0.73	0.00
Neural stem cells, donor2	11352-117H2	34.66	32.74	0.00	0.00	0.00
Neurons, donor1	11494-119E9	26.17	35.27	2.28	0.00	0.00
Neurons, donor2	11574-120E8	30.60	28.40	0.88	0.88	0.22
Neurons, donor3	11655-122E8	23.84	25.49	1.64	2.47	1.64
Neutrophils, donor1	11233-116C9	8.35	10.21	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	14.49	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	12.22	17.71	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	35.15	24.70	1.07	0.95	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	13.68	11.07	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	16.04	16.65	0.40	0.40	0.80
Olfactory epithelial cells, donor1	11933-125I7	33.72	9.64	0.55	0.55	0.28
Olfactory epithelial cells, donor2	11934-125I8	29.96	18.24	1.01	0.58	0.29
Olfactory epithelial cells, donor3	11935-125I9	27.81	12.94	0.45	1.02	0.23
Olfactory epithelial cells, donor4	11936-126A1	36.62	14.71	0.49	0.68	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	19.86	0.00	1.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	32.97	31.69	0.64	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	13.72	17.15	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	11.79	10.55	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	27.56	20.72	1.37	0.78	0.78
Osteoblast, donor2	11354-117H4	23.18	20.37	2.11	0.70	0.00
Osteoblast, donor3	11426-118G4	27.19	26.48	1.07	0.00	0.53
Pancreatic stromal cells, donor1	11249-116E7	32.60	19.63	1.01	0.93	0.25
Pericytes, donor1	11491-119E6	13.91	14.13	0.11	0.56	0.00
Pericytes, donor2	11571-120E5	19.92	13.36	0.45	1.13	0.00
Pericytes, donor3	11652-122E5	20.96	17.50	0.00	1.22	0.41
Perineurial Cells, donor1	11499-119F5	29.72	15.60	0.68	0.68	0.45
Perineurial Cells, donor2	11579-120F4	28.98	21.62	1.20	0.46	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.77	32.83	0.64	0.00	2.55
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	38.20	24.98	0.98	1.22	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	36.88	20.32	0.65	0.39	0.39
Placental Epithelial Cells, donor1	11278-116H9	10.76	8.13	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	28.83	6.65	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	22.18	9.62	0.59	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.72	17.09	0.32	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	30.95	23.07	0.94	1.88	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.84	13.05	0.39	0.13	0.91
Preadipocyte - breast, donor2	11328-117E5	28.82	18.24	0.45	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	35.48	24.30	1.07	1.17	1.39
Preadipocyte - omental, donor2	11329-117E6	34.92	26.19	2.62	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	25.36	24.35	2.01	0.43	1.43
Preadipocyte - perirenal, donor1	11469-119C2	25.59	21.65	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.83	20.88	0.00	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	14.17	19.30	0.71	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	18.73	21.29	1.19	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	20.86	25.80	1.12	1.02	0.37
Preadipocyte - visceral, donor2	11357-117H7	17.95	17.03	1.84	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	13.17	20.27	0.31	1.25	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.38	16.90	1.21	0.91	0.75
Prostate Epithelial Cells, donor2	11331-117E8	13.54	14.90	0.81	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	4.10	19.53	0.24	0.00	0.12
Prostate Stromal Cells, donor1	11254-116F3	31.55	25.06	1.59	2.62	0.46
Prostate Stromal Cells, donor2	11332-117E9	19.36	23.85	0.72	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	18.25	13.56	0.83	0.63	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	15.33	18.61	0.73	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.08	19.75	0.14	0.14	0.21
Renal Epithelial Cells, donor1	11517-119H5	11.16	14.20	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.21	19.92	0.00	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	25.30	27.95	0.11	1.38	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	15.66	17.02	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.14	26.01	1.62	0.54	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	17.32	14.65	1.33	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	4.66	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	18.05	20.69	1.10	0.66	0.44
Renal Mesangial Cells, donor2	11598-120H5	20.06	21.94	1.88	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	9.15	10.82	0.28	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.59	29.79	0.00	0.81	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.49	19.82	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	24.49	17.36	0.00	0.77	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.30	21.26	0.26	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	35.81	20.75	0.57	1.14	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	9.26	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.57	15.05	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.81	21.52	0.80	1.07	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	31.27	11.61	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	35.22	7.71	0.00	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	44.08	9.86	0.58	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.11	15.47	1.43	1.82	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	32.57	10.23	1.09	1.19	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	40.38	17.40	2.12	2.79	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	42.30	15.13	2.23	1.98	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	31.47	11.19	1.17	1.75	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	38.14	15.25	0.92	1.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	27.66	10.54	0.96	0.96	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	32.83	10.74	1.36	0.91	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	36.91	11.83	1.25	2.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	30.56	14.20	0.72	1.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	25.97	12.13	1.40	1.61	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	32.75	7.97	1.77	1.33	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.29	8.22	1.34	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	31.95	10.25	1.49	1.30	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	46.04	18.79	2.07	2.07	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	30.39	13.80	1.19	2.39	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	31.64	11.78	2.14	1.36	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	38.00	11.84	0.76	1.34	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.06	10.36	1.17	1.28	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	33.92	10.65	1.40	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	33.67	18.29	1.54	1.88	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	27.90	8.20	1.82	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	29.43	8.34	1.72	1.72	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	37.07	11.95	1.07	0.94	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	22.41	10.61	2.12	2.12	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	33.53	11.31	0.99	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	36.48	14.50	2.57	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.96	11.20	1.87	1.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	29.20	12.61	2.43	1.99	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.78	12.53	1.46	1.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.47	15.07	1.62	1.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	26.74	9.20	2.04	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.23	14.85	2.70	1.93	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	24.76	13.93	1.89	1.03	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.59	9.88	0.27	0.82	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	29.55	13.79	1.97	1.31	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	28.97	9.20	1.02	1.19	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.37	12.87	2.07	1.48	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	28.25	10.40	0.53	1.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	39.82	15.07	1.94	1.38	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	41.43	14.52	1.67	1.67	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.52	9.07	2.02	1.61	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	34.94	7.44	1.79	0.75	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	44.72	18.17	2.45	3.14	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	53.79	13.90	2.42	2.42	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	36.35	9.67	1.10	1.35	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	80.93	21.54	3.20	3.35	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	65.10	16.43	0.61	1.22	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	31.35	10.85	1.51	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	65.37	17.87	3.17	2.49	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	63.50	16.18	0.90	2.40	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	61.63	23.02	2.72	2.72	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	64.46	15.79	4.27	2.13	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	55.29	24.64	1.80	4.81	0.00
Schwann Cells, donor1	11498-119F4	18.62	11.47	0.38	0.38	0.00
Schwann Cells, donor2	11578-120F3	10.21	13.61	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.14	13.36	0.22	0.44	0.00
Sebocyte, donor1	11220-116B5	25.20	29.58	1.64	2.74	0.00
Sebocyte, donor2	11301-117B5	10.11	14.25	0.46	0.00	0.92
Sebocyte, donor3	11378-118B1	12.37	15.05	0.62	0.21	0.00
Sertoli Cells, donor1	11255-116F4	38.10	23.19	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	36.72	14.12	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	30.00	26.48	0.35	1.23	0.09
Skeletal Muscle Cells, donor2	11358-117H8	9.40	9.40	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	24.25	24.25	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	17.75	21.84	0.94	1.26	0.31
Skeletal Muscle Cells, donor5	11455-119A6	21.70	21.40	0.45	0.74	0.45
Skeletal Muscle Cells, donor6	11459-119B1	13.85	24.62	0.62	0.31	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	29.11	28.48	0.38	1.39	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.69	24.97	0.29	0.86	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.06	19.25	1.09	0.50	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	27.21	24.43	0.67	1.26	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.13	10.86	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	22.02	21.47	0.69	0.69	0.28
Skin - palm, donor1	10286-104F7	29.55	8.06	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.50	11.10	0.58	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.90	37.62	3.27	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.93	7.66	0.39	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	10.56	16.54	0.97	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	10.41	12.24	0.42	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	39.75	49.27	1.06	1.48	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	8.47	16.56	0.75	0.45	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.49	15.12	0.31	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.24	26.46	2.45	2.45	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	25.86	2.35	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	43.09	17.02	0.88	1.33	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	17.33	24.81	1.18	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	26.27	30.13	0.00	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	16.01	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	26.62	22.22	1.06	1.33	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	22.83	25.71	1.77	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	27.78	25.35	1.66	1.02	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.33	15.30	0.98	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	24.22	26.87	0.00	1.77	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.08	16.09	0.71	1.42	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.20	14.64	0.49	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.70	14.92	0.00	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	28.79	26.52	0.76	1.26	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.12	9.54	1.43	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	16.66	13.72	0.29	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.23	14.64	0.22	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.90	16.69	1.05	1.15	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.26	23.51	1.39	0.62	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	24.79	3.23	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.61	23.31	0.90	1.49	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.92	15.36	0.00	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	31.88	15.00	0.24	0.79	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	25.46	35.53	1.61	0.91	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.75	18.43	0.91	1.59	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.91	19.93	1.21	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.54	24.37	0.26	1.32	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.90	27.03	1.86	0.93	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.03	21.41	0.63	0.75	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.32	16.74	0.76	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.93	28.80	1.36	1.51	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	15.00	2.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	171.86	11.63	1.29	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.11	31.62	0.00	3.26	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.67	15.15	0.00	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	19.43	17.55	2.19	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.32	19.47	0.59	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	17.08	26.08	0.33	0.75	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	17.28	12.61	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.89	21.59	2.01	1.01	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	20.65	13.77	2.29	0.25	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	23.32	15.61	0.94	1.32	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	26.55	26.13	0.14	1.26	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.82	19.10	0.34	0.67	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	5.24	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	22.51	17.62	0.98	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	23.64	24.97	0.66	0.66	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.83	7.90	0.59	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	35.96	13.99	0.39	1.17	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.60	8.99	0.26	2.12	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	25.66	11.16	0.37	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	18.69	19.04	1.08	0.00	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.22	12.21	0.85	1.14	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.79	12.60	1.18	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	24.63	15.74	0.76	2.03	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	30.35	17.17	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	18.81	9.61	0.00	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	21.08	13.75	0.00	0.92	0.00
Synoviocyte, donor1	11291-117A4	25.25	15.49	0.84	1.35	0.84
Synoviocyte, donor2	11368-117I9	21.29	23.97	0.67	0.34	0.67
Synoviocyte, donor3	11440-118H9	24.58	19.88	0.67	0.22	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	28.23	21.80	2.14	1.43	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	3.96	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.44	8.34	0.46	0.46	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	10.75	18.28	0.36	0.22	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	15.85	0.00	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	10.88	11.45	0.57	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	36.42	26.33	0.25	0.62	0.49
Urethra, donor2	10319-105A4	32.37	17.98	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	9.03	14.08	0.00	0.53	0.27
Urothelial Cells, donor2	11600-120H7	12.02	11.62	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	12.84	9.40	0.46	0.23	0.46
Urothelial cells, donor0	11216-116B1	29.20	20.51	0.45	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	20.47	21.35	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	42.89	34.31	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	12.32	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	36.50	18.25	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.63	19.75	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	24.99	26.03	0.00	1.04	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	30.29	29.37	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	13.69	10.04	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	14.80	11.35	0.86	0.37	0.37
Wilms' tumor cell line:HFWT	10597-108E3	30.80	11.44	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.97	9.22	0.28	0.00	1.12
achilles tendon, donor2	10292-104G4	24.80	12.40	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	8.92	18.87	1.02	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.38	22.52	0.00	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	43.57	24.69	1.31	0.71	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	27.21	43.81	0.82	2.45	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.90	17.71	0.84	0.00	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	19.03	16.71	1.48	1.06	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.34	10.62	0.54	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.03	16.30	3.08	1.32	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.07	9.39	0.41	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	42.71	25.24	2.72	1.94	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	14.54	20.61	1.29	1.66	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	11.70	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	15.57	16.27	0.23	0.46	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	24.08	20.71	0.00	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.96	12.57	1.17	0.88	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.91	10.22	1.39	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	18.92	7.40	1.23	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	9.52	9.82	0.61	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.04	16.21	0.00	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	20.02	18.20	1.21	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	20.94	18.78	1.20	1.20	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	25.61	17.60	1.11	1.11	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.01	15.34	0.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	9.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.16	10.17	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.48	14.39	2.18	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	22.49	16.87	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.25	13.42	0.24	0.24	1.18
adipose tissue, adult, pool1	10010-101C1	36.14	16.60	0.47	0.16	0.16
adipose, donor1	10184-103D4	59.81	40.46	1.76	0.00	0.00
adipose, donor2	10185-103D5	10.54	12.98	0.41	0.41	0.41
adipose, donor3	10186-103D6	19.06	12.53	0.82	1.09	0.82
adipose, donor4	10187-103D7	24.27	17.34	1.73	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.52	15.15	0.32	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	10.91	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	5.07	9.21	0.27	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.51	5.72	1.79	0.00	1.43
amniotic membrane cells, donor1	12235-129G3	28.98	25.74	0.93	1.16	0.70
amniotic membrane cells, donor2	12236-129G4	51.39	28.06	1.69	1.35	1.01
amniotic membrane cells, donor3	12237-129G5	30.64	33.58	0.29	0.00	0.59
amygdala - adult, donor10196	10167-103B5	11.86	35.57	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	18.25	31.43	0.61	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	11.62	18.08	1.29	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	67.74	26.74	0.64	0.64	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	6.62	11.69	0.00	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.73	19.37	4.34	0.33	0.67
aorta, adult, pool1	10052-101G7	41.19	19.42	0.78	0.98	0.39
appendix, adult	10189-103D9	33.77	25.23	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.78	20.64	3.78	2.75	2.06
artery, adult	10190-103E1	21.74	17.66	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	53.75	17.09	1.16	0.29	1.16
b cell line:RPMI1788	10427-106D4	23.20	24.98	0.59	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	29.96	13.32	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.11	13.99	0.10	0.30	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	18.58	7.03	0.17	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.10	5.59	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	28.14	16.08	0.11	0.54	0.22
blood, adult, pool1	10053-101G8	13.29	13.29	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	32.54	17.98	0.86	0.00	0.86
bone marrow, adult	10192-103E3	39.81	17.55	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	22.55	21.53	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	21.60	22.49	0.45	0.45	0.45
brain, fetal, pool1	10085-102B4	34.73	45.41	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	91.51	90.85	7.93	6.94	4.29
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.97	30.83	0.87	1.12	0.37
breast, adult, donor1	10080-102A8	12.00	16.42	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	18.29	17.79	1.14	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	81.32	15.77	3.71	1.86	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	23.02	18.88	0.23	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	24.93	17.19	0.48	0.48	1.45
carcinoid cell line:NCI-H1770	10703-109H1	19.75	11.28	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	20.89	12.91	2.08	0.11	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	5.07	10.77	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	33.80	22.09	0.53	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	17.27	37.99	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	18.24	56.39	1.00	1.17	0.84
caudate nucleus, adult, donor10258	10379-105H1	10.70	58.07	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	16.85	20.51	0.37	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	67.01	49.53	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	67.90	51.88	2.35	0.64	0.85
cerebellum, adult, pool1	10083-102B2	39.32	20.01	1.03	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	67.25	31.55	3.32	0.00	0.00
cerebral meninges, adult	10188-103D8	26.22	29.50	0.76	0.76	1.01
cerebrospinal fluid, donor2	10294-104G6	10.96	10.23	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	35.95	36.23	0.29	0.43	0.43
cervical cancer cell line:ME-180	10553-107I4	30.82	29.17	1.49	0.83	0.99
cervix, adult, pool1	10013-101C4	44.20	18.79	0.31	0.42	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	51.69	20.34	0.70	0.98	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	43.11	9.14	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	39.02	11.31	0.62	0.50	0.12
choriocarcinoma cell line:SCH	10785-110H2	52.98	17.62	1.72	0.12	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	15.89	9.49	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	33.34	18.23	0.57	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	31.52	20.38	1.09	0.40	0.60
chorionic membrane cells, donor3	12240-129G8	46.71	12.09	0.55	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	14.14	2.02	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	19.79	16.33	1.34	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	19.64	10.98	1.06	1.27	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.76	11.04	0.26	0.00	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	12.34	15.24	0.73	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.59	12.01	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	27.68	27.97	0.29	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	19.29	17.46	1.30	0.52	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	25.37	11.20	0.69	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	38.69	18.91	0.35	0.35	2.43
colon carcinoma cell line:CACO-2	10513-107D9	37.89	18.67	0.92	1.28	1.10
colon carcinoma cell line:COLO-320	10420-106C6	103.76	23.18	4.18	0.38	3.80
colon, adult, donor1	10082-102B1	44.03	26.18	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	28.79	18.92	0.94	0.94	0.35
colon, fetal, donor1	10070-101I7	24.72	11.74	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	50.42	77.92	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.90	14.02	2.12	0.85	2.97
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.58	10.72	0.60	0.30	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	14.10	10.86	0.85	0.14	1.27
corpus callosum, adult, pool1	10042-101F6	45.77	25.87	0.22	0.77	0.22
cruciate ligament, donor2	10295-104G7	36.47	8.10	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	26.48	15.25	0.00	0.00	0.80
diencephalon, adult	10193-103E4	14.16	18.72	0.24	1.44	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	18.83	20.89	0.69	0.46	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	23.08	30.26	0.26	1.28	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	29.37	28.41	0.96	0.96	0.96
ductus deferens, adult	10196-103E7	34.39	21.43	0.50	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	20.16	28.80	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.84	28.69	0.74	0.74	0.74
dura mater, adult, donor1	10041-101F5	44.68	29.57	1.73	0.50	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	9.99	15.99	2.22	0.00	5.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	25.79	40.41	1.72	1.58	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	42.55	14.18	1.85	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	36.63	14.83	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	48.78	12.97	1.85	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	72.24	24.96	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	14.41	14.08	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	91.52	21.57	1.81	1.45	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.05	12.54	2.09	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	31.24	18.79	1.00	1.11	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	41.90	27.50	0.44	1.21	0.22
epididymis, adult	10197-103E8	38.30	18.84	0.63	0.42	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	51.80	29.10	0.35	0.71	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.09	7.86	0.79	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	29.49	21.49	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.39	19.98	0.69	0.98	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	25.99	28.46	1.12	0.34	0.34
esophagus, adult, pool1	10015-101C6	23.25	12.21	0.32	0.85	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	67.38	27.30	0.63	0.75	0.13
eye - muscle inferior rectus, donor1	10272-104E2	24.15	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	8.42	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	26.79	11.91	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	9.17	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	33.52	10.20	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	36.36	32.54	1.02	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	27.95	10.90	0.51	0.26	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	17.33	21.37	0.47	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	33.50	38.56	1.31	0.84	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	24.92	17.11	0.00	0.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	67.39	11.89	0.73	0.82	1.74
gall bladder, adult	10198-103E9	32.83	17.38	0.72	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	41.34	27.38	0.54	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	38.47	23.16	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	18.59	27.67	0.21	0.00	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	23.60	16.63	0.00	1.55	0.00
gastric cancer cell line:AZ521	10549-107H9	27.71	17.38	0.66	1.15	0.33
gastric cancer cell line:GSS	10560-108A2	9.15	11.90	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.79	18.51	3.66	0.46	0.91
giant cell carcinoma cell line:LU65	10487-107B1	19.39	14.80	0.80	0.11	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	37.09	21.27	0.14	0.56	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	7.48	14.47	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	24.91	12.56	1.06	0.74	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.21	13.34	1.40	0.14	0.98
glioblastoma cell line:T98G	10485-107A8	39.18	17.66	0.55	0.33	0.55
glioma cell line:GI-1	10413-106B8	36.02	10.84	2.05	0.88	0.88
globus pallidus - adult, donor10196	10175-103C4	25.51	29.16	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	25.87	28.07	0.24	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	13.69	13.69	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.13	17.05	0.53	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	56.28	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	26.13	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.68	10.88	0.64	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	10.10	14.69	0.92	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	8.69	10.97	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.81	14.17	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	1.44	14.37	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	14.40	8.92	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	8.83	16.55	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	8.05	14.08	0.00	0.86	0.29
heart - mitral valve, adult	10205-103F7	36.77	32.59	4.19	0.90	1.49
heart - pulmonic valve, adult	10206-103F8	31.90	32.42	1.05	0.78	0.78
heart - tricuspid valve, adult	10207-103F9	21.65	49.96	0.83	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	34.49	41.02	2.65	1.63	0.61
heart, adult, diseased, donor1	10051-101G6	48.54	66.00	6.39	1.70	2.98
heart, adult, pool1	10016-101C7	26.45	36.11	0.92	0.69	0.69
heart, fetal, pool1	10046-101G1	99.29	143.55	8.32	6.67	3.80
hepatic mesenchymal tumor cell line:LI90	10778-110G4	29.93	19.44	0.62	1.85	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	16.65	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	41.77	16.80	1.66	1.33	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	42.12	18.93	2.18	1.34	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	46.08	17.58	1.92	0.71	0.51
hepatoma cell line:Li-7	10484-107A7	18.13	10.79	0.89	0.00	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.66	17.99	0.60	0.70	0.30
hippocampus - adult, donor10196	10169-103B7	14.19	34.07	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	27.15	31.64	0.61	0.41	0.41
hippocampus, adult, donor10258	10374-105G5	13.94	22.91	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	11.28	19.74	0.00	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	35.40	15.26	0.00	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	16.10	10.80	0.39	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	19.04	9.65	0.76	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	21.43	15.79	0.56	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	18.85	12.39	0.77	0.00	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	21.26	14.43	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	20.44	22.19	0.29	0.00	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	14.00	21.33	0.22	0.00	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	14.18	16.27	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.89	8.76	0.95	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.34	12.05	0.80	0.32	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	9.43	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.34	9.86	0.47	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	16.70	10.81	1.97	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	7.85	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	25.77	13.75	0.38	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.93	21.80	0.44	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	38.48	25.49	0.50	1.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	15.64	16.58	0.00	0.00	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	19.55	16.82	0.91	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.66	14.41	0.31	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.68	12.41	0.82	0.16	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	15.68	9.58	0.87	0.58	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.91	11.66	0.90	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.37	10.16	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.68	12.27	1.43	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	31.85	15.92	0.00	0.82	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	19.01	15.84	0.70	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	18.69	15.52	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	22.09	14.53	0.00	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	12.93	1.55	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.28	12.62	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.88	13.34	0.26	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.45	15.34	1.02	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.17	19.69	0.00	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.47	14.45	0.34	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	16.66	8.21	0.24	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.51	8.47	0.89	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.49	8.78	0.98	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	20.48	17.42	0.00	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	78.08	45.55	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.81	23.17	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.04	16.42	0.00	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.84	17.01	0.00	0.72	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	14.95	15.30	1.42	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	14.32	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	23.70	17.88	0.68	0.95	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	17.78	14.82	0.00	0.27	0.27
immature langerhans cells, donor1	11904-125F5	22.28	11.38	0.73	0.97	0.00
immature langerhans cells, donor2	11905-125F6	15.84	15.84	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	34.35	56.40	1.23	0.95	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	26.99	13.33	1.30	0.00	1.30
kidney, adult, pool1	10017-101C8	26.03	27.33	0.20	0.70	0.30
kidney, fetal, pool1	10045-101F9	56.80	40.53	0.92	0.78	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	59.93	28.55	4.12	0.71	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.41	10.51	0.69	0.00	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.93	16.15	0.55	0.00	0.18
left atrium, adult, donor1	10079-102A7	15.80	12.53	1.09	0.00	1.63
left ventricle, adult, donor1	10078-102A6	23.26	20.23	0.00	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	23.80	21.07	0.82	1.64	0.27
leiomyoma cell line:10964C	10569-108B2	17.24	27.30	1.44	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	12.50	25.00	1.63	1.63	0.54
leiomyoma cell line:15425	10571-108B4	17.24	29.38	1.21	0.24	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	31.75	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	15.68	9.41	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.15	20.19	3.78	0.47	0.59
liposarcoma cell line:KMLS-1	10782-110G8	24.99	17.65	0.62	0.62	0.47
liposarcoma cell line:SW 872	10726-110A6	50.81	18.64	0.37	0.85	0.24
liver, adult, pool1	10018-101C9	32.74	21.07	1.13	0.65	0.81
liver, fetal, pool1	10086-102B5	9.41	9.41	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.44	18.67	0.29	0.58	0.15
locus coeruleus, adult, donor10252	10165-103B3	20.30	28.05	0.55	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	7.34	15.80	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	18.51	15.98	0.00	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	22.28	7.61	0.00	1.25	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	31.02	20.68	0.00	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	46.40	12.92	1.85	0.26	0.53
lung, adult, pool1	10019-101D1	28.94	16.18	0.35	0.00	1.18
lung, fetal, donor1	10068-101I5	67.93	65.64	2.57	2.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	30.70	19.25	0.46	0.92	0.46
lymph node, adult, donor1	10077-102A5	17.99	13.73	0.95	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	28.27	38.36	8.99	2.19	3.51
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	15.85	19.02	2.41	0.30	2.11
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	39.93	32.28	0.85	1.70	0.00
mature adipocyte, donor1	12231-129F8	29.75	33.30	0.00	1.33	1.78
mature adipocyte, donor2	12232-129F9	34.45	32.58	0.83	0.62	0.62
mature adipocyte, donor3	12233-129G1	34.61	20.86	0.95	0.71	0.71
mature adipocyte, donor4	12234-129G2	42.38	30.01	0.79	0.53	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.83	15.25	4.77	1.19	5.00
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	32.71	0.00	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	20.78	36.78	0.92	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	17.79	27.64	0.64	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	24.74	29.85	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	21.43	41.18	0.51	1.01	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	24.62	36.93	0.64	0.85	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	28.89	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.69	21.18	0.00	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	22.07	15.58	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	28.33	22.14	0.15	0.31	0.62
medulla oblongata, adult, pool1	10038-101F2	30.12	26.28	0.57	0.57	0.24
medulla oblongata, newborn, donor10223	10361-105F1	17.36	12.15	0.00	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	20.15	14.39	1.11	0.66	0.44
medulloblastoma cell line:ONS-76	10759-110E3	19.07	18.71	1.35	1.10	1.22
melanoma cell line:COLO 679	10514-107E1	27.31	10.64	2.73	0.57	1.44
melanoma cell line:G-361	10465-106H6	32.85	18.46	0.81	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	18.99	13.03	0.00	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	39.65	27.32	5.29	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	16.85	25.66	1.04	0.78	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	14.12	29.61	0.46	0.92	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.18	13.82	0.91	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.05	22.36	0.83	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.85	19.53	1.12	0.98	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	23.30	24.65	0.96	0.58	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	17.35	25.68	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	22.31	18.02	1.03	0.69	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.01	20.13	1.38	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.02	20.96	0.66	0.40	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.83	24.71	1.62	0.81	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	27.88	27.74	0.85	1.42	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.70	15.48	1.32	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	27.67	19.65	0.42	0.69	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.20	22.34	0.70	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.79	20.82	0.82	1.02	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.02	9.71	0.00	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	31.24	15.62	0.31	0.72	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.96	10.03	0.23	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	18.88	28.53	0.00	1.68	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.91	12.55	1.79	0.15	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	28.62	17.94	1.58	0.44	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	33.87	17.67	0.74	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.89	18.31	1.14	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.47	18.95	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.07	21.01	1.37	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.07	13.56	0.77	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	19.11	20.94	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	23.72	22.49	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.06	16.71	0.47	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.25	23.35	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.29	22.01	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.00	20.39	0.46	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.69	25.67	0.58	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.62	24.76	0.22	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.47	22.59	0.96	1.20	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	18.33	33.00	1.47	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.80	17.45	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.97	20.47	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.03	18.90	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	21.88	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	20.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.49	20.79	1.62	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	14.55	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.92	25.59	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	22.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.05	15.94	1.55	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	6.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	14.90	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	25.50	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	23.15	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	26.60	20.90	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.00	17.25	0.69	0.34	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	15.04	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	7.98	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	17.22	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.89	17.11	1.22	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	13.51	2.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.63	11.20	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.39	11.84	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	9.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	14.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	10.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	13.77	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.33	12.86	1.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	16.82	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.90	13.99	0.64	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.09	15.31	1.21	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	17.44	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	13.94	0.00	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.78	23.67	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.12	18.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	21.03	19.25	0.79	0.99	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	18.50	14.60	0.32	0.32	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	23.43	22.41	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	45.65	7.74	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	21.26	9.21	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	43.32	26.41	1.16	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	27.02	10.79	1.44	0.31	0.92
mesothelioma cell line:Mero-25	10850-111F4	24.74	23.83	0.91	0.23	0.68
mesothelioma cell line:Mero-41	10851-111F5	13.20	10.02	1.71	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	22.59	12.62	1.77	1.11	0.66
mesothelioma cell line:Mero-82	10853-111F7	19.45	17.35	0.79	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	15.83	11.06	1.53	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	3.54	12.39	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	30.85	15.32	0.21	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	19.88	8.94	0.66	0.50	0.17
mesothelioma cell line:NCI-H226	10846-111E9	16.83	8.33	0.36	0.54	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	29.21	12.98	0.85	0.51	0.51
mesothelioma cell line:NCI-H28	10845-111E8	11.96	9.42	0.76	0.25	0.25
mesothelioma cell line:No36	10857-111G2	18.27	11.09	0.65	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	14.09	7.86	1.35	1.35	0.54
migratory langerhans cells, donor1	11901-125F2	18.42	13.24	1.15	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	13.07	18.20	0.24	0.24	0.73
migratory langerhans cells, donor3	11903-125F4	11.13	16.33	0.18	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	27.42	14.69	0.33	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.50	8.90	1.91	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	18.43	14.05	0.92	0.23	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.66	8.56	0.38	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	44.90	20.14	1.11	0.37	1.11
myeloma cell line:PCM6	10474-106I6	21.74	10.87	0.40	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	23.84	23.34	1.01	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.89	8.43	0.20	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	5.13	22.06	0.33	0.33	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.93	21.25	0.00	0.37	0.15
nasal epithelial cells, donor2	12227-129F4	11.04	15.46	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	26.00	19.10	1.38	0.46	0.69
neuroblastoma cell line:NB-1	10539-107G8	13.47	28.62	1.12	0.37	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	27.20	9.07	2.95	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	46.77	28.88	1.49	0.37	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.23	29.65	0.95	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.96	36.11	0.63	0.32	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	17.51	13.48	0.20	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	8.90	8.90	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	20.49	12.51	0.27	0.27	0.27
neutrophil PMN, donor1	12133-128D9	14.87	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	47.86	24.18	0.68	0.51	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	28.02	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	31.74	24.69	0.96	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.44	14.45	0.26	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	27.56	53.34	1.22	1.31	1.03
occipital cortex - adult, donor10196	10172-103C1	18.54	30.91	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	30.06	30.86	1.88	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	7.64	20.02	0.00	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	25.98	31.49	1.31	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	42.05	37.76	1.72	1.29	0.00
occipital pole, adult, pool1	10036-101E9	31.06	36.11	1.10	0.95	0.47
olfactory region, adult	10195-103E6	18.72	21.97	0.57	0.57	0.19
optic nerve, donor1	10277-104E7	30.02	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	104.00	24.15	8.20	0.91	5.24
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	15.11	6.46	0.41	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	23.71	14.22	0.51	0.34	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	12.24	13.28	0.46	0.35	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	27.04	17.64	1.47	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	55.13	14.02	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	40.72	14.42	3.39	0.42	2.54
ovary, adult, pool1	10020-101D2	41.40	20.61	0.52	0.61	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.25	17.97	0.55	0.00	0.55
pancreas, adult, donor1	10049-101G4	40.45	29.16	1.88	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.63	5.03	1.68	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	43.61	17.38	1.87	0.51	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.31	13.74	0.50	0.17	0.66
paracentral gyrus, adult, pool1	10035-101E8	27.37	41.83	0.92	0.92	0.73
parietal cortex, adult, donor10258	10373-105G4	13.21	31.56	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	14.11	31.04	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	24.23	35.06	0.57	0.00	1.14
parietal lobe, adult, pool1	10034-101E7	30.93	42.91	0.79	0.79	0.35
parietal lobe, fetal, donor1	10072-101I9	51.40	62.07	3.88	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.59	24.30	0.00	0.00	0.00
parotid gland, adult	10199-103F1	30.83	20.97	0.62	0.62	1.85
penis, adult	10200-103F2	36.52	16.11	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.13	20.27	0.56	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	32.20	24.62	0.87	0.44	0.29
pineal gland - adult, donor10196	10179-103C8	52.89	89.01	5.81	8.39	1.29
pineal gland, adult, donor10252	10160-103A7	57.44	114.30	4.15	3.55	1.18
pineal gland, adult, donor10258	10377-105G8	44.52	43.27	3.76	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	50.59	71.84	3.04	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	79.74	104.76	5.21	2.61	2.61
pituitary gland, adult, donor10258	10378-105G9	69.80	62.99	4.26	1.70	2.55
placenta, adult, pool1	10021-101D3	46.01	18.60	0.86	0.22	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	9.27	7.68	0.53	0.00	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	33.00	14.79	1.09	0.00	1.09
pons, adult, pool1	10033-101E6	21.09	21.69	0.60	0.77	0.34
postcentral gyrus, adult, pool1	10032-101E5	31.03	37.92	1.05	0.61	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	33.46	2.09	2.09	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	38.45	21.41	1.17	0.44	1.17
prostate cancer cell line:PC-3	10439-106E7	27.77	28.50	0.36	0.54	0.18
prostate, adult, pool1	10022-101D4	28.21	21.31	0.73	0.73	0.36
putamen, adult, donor10196	10176-103C5	16.29	85.69	1.42	0.47	0.47
putamen, adult, donor10252	10152-102I8	15.69	47.06	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	10.93	21.86	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.39	41.80	0.48	1.69	0.00
putamen, newborn, donor10223	10365-105F5	11.24	9.75	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	25.89	9.89	0.00	0.00	0.58
rectum, fetal, donor1	10067-101I4	43.12	20.86	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	32.01	18.23	1.06	1.27	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.36	11.60	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	66.80	35.98	1.19	1.39	0.70
retinoblastoma cell line:Y79	10475-106I7	52.22	25.46	2.86	1.82	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	23.85	23.85	1.23	0.86	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.09	10.40	1.41	1.69	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	36.38	15.91	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	21.85	17.16	0.16	0.65	0.49
salivary acinar cells, donor2	11772-123I8	26.02	16.94	0.96	0.28	0.28
salivary acinar cells, donor3	11773-123I9	33.10	16.55	0.66	0.66	0.66
salivary gland, adult, pool1	10093-102C3	56.05	34.89	0.00	2.86	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	18.63	6.32	0.59	0.25	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.51	6.35	0.12	0.24	0.00
seminal vesicle, adult	10201-103F3	30.69	17.46	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.26	26.72	1.46	0.24	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	19.88	23.15	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	29.10	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	42.85	51.31	2.42	1.75	3.76
signet ring carcinoma cell line:Kato III	10436-106E4	21.33	16.58	0.11	0.33	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.87	14.97	0.90	0.13	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	16.31	10.64	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	14.75	9.36	0.00	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	19.10	17.09	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	62.49	44.19	1.26	0.63	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	20.34	23.35	1.33	1.00	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.27	16.39	1.89	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	62.64	37.01	1.35	1.35	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	28.52	27.36	3.30	0.16	3.46
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.47	19.62	0.64	0.48	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	22.23	12.20	1.74	0.87	0.44
small intestine, adult, pool1	10024-101D6	30.58	26.87	0.48	0.48	0.48
small intestine, fetal, donor1	10064-101I1	28.50	15.97	0.49	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	30.77	20.00	1.03	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	29.72	16.28	0.26	1.55	0.00
somatostatinoma cell line:QGP-1	10781-110G7	32.43	16.08	2.14	1.88	0.80
spinal cord - adult, donor10196	10181-103D1	15.83	17.66	0.46	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	16.95	22.08	0.39	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	19.37	13.84	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	42.69	31.71	1.22	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	35.36	16.07	0.92	0.46	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.31	17.03	0.90	0.90	0.00
spleen, adult, pool1	10025-101D7	35.79	15.97	0.55	0.77	0.00
spleen, fetal, pool1	10044-101F8	46.00	23.68	0.79	0.64	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.73	14.39	0.72	0.10	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	44.24	24.49	0.76	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	45.78	33.90	1.75	1.40	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.20	18.37	0.78	0.78	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	46.49	41.08	0.45	0.34	1.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.13	13.13	1.69	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	33.85	4.65	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	35.24	27.77	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	38.74	25.07	1.14	0.57	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.98	24.30	1.04	0.21	0.83
substantia nigra, adult, donor10258	10371-105G2	9.83	21.72	1.55	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.02	21.20	0.71	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	55.94	52.27	2.06	2.06	0.00
temporal lobe, adult, pool1	10031-101E4	28.91	38.23	1.19	0.76	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	27.07	64.82	2.14	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	23.30	43.07	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	28.28	22.69	0.70	1.05	0.70
tenocyte, donor2	11765-123I1	29.76	19.84	0.76	1.14	0.00
tenocyte, donor3	11768-123I4	18.90	20.02	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	13.26	12.24	1.02	0.68	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	15.72	10.17	0.31	0.15	0.46
teratocarcinoma cell line:PA-1	10807-111A6	17.20	13.02	0.46	0.31	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.33	14.09	1.27	0.63	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	26.47	12.48	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.81	13.09	0.65	0.11	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	21.50	11.73	0.33	0.33	0.65
testis, adult, pool1	10026-101D8	33.18	21.58	1.18	0.32	0.43
testis, adult, pool2	10096-102C6	41.95	29.77	1.80	0.45	0.00
thalamus - adult, donor10196	10168-103B6	17.66	18.77	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	23.75	30.48	0.31	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	21.55	0.00	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.89	8.56	0.82	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	6.33	7.48	1.73	0.58	0.00
throat, adult	10209-103G2	27.46	19.22	1.00	0.25	1.00
throat, fetal, donor1	10061-101H7	42.66	32.91	0.91	0.61	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	15.30	30.01	1.19	0.00	0.60
thymus, adult, pool1	10027-101D9	35.79	27.84	0.70	0.40	0.40
thymus, fetal, pool1	10043-101F7	40.31	44.89	0.52	0.31	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.54	15.02	0.53	0.53	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	22.07	17.60	0.70	0.42	0.28
thyroid, adult, pool1	10028-101E1	48.90	53.00	0.75	1.12	0.37
thyroid, fetal, donor1	10060-101H6	42.98	40.87	1.32	0.53	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	12.32	0.00	3.08	0.00
tongue, adult	10203-103F5	24.89	11.40	0.23	0.00	0.93
tongue, fetal, donor1	10059-101H5	27.59	21.28	0.39	0.79	0.39
tonsil, adult, pool1	10047-101G2	42.88	26.15	1.30	0.50	0.70
trachea, adult, pool1	10029-101E2	27.08	27.48	1.06	0.65	0.57
trachea, fetal, donor1	10058-101H4	35.78	29.24	1.92	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.07	18.78	1.06	1.06	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	14.79	15.20	0.61	0.41	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	103.88	21.31	2.66	0.94	0.47
tridermal teratoma cell line:HGRT	10694-109G1	53.27	22.83	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	33.10	14.31	0.08	0.76	0.17
umbilical cord, fetal, donor1	10057-101H3	41.73	14.61	2.09	4.17	2.09
uterus, adult, pool1	10100-102D1	56.65	35.32	1.54	1.02	0.68
uterus, fetal, donor1	10055-101H1	43.00	36.86	2.05	2.05	0.00
vagina, adult	10204-103F6	13.57	23.91	0.00	0.00	0.00
vein, adult	10191-103E2	25.21	19.29	0.88	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.01	5.34	1.07	0.27	0.00